Advanced Search

 

Study ID Status Title Patient Level Data
200926 Active, Not Recruiting A Non-randomized, Open-label, Phase II Study to Assess the Safety and Efficacy of Eltrombopag in Japanese Subjects with Refractory, Moderate or More Severe Aplastic Anemia
200928 Not yet recruiting A multi-centre, randomised, double-blind (sponsor open), placebo-controlled, repeat dose, proof of mechanism study to evaluate the safety and tolerability, pharmacokinetics, pharmacodynamics and clinical efficacy of GSK3050002 in subjects with psoriatic arthritis
200934 Completed An Open Label Study on the Effects of a Short Course of SB480848 (Darapladib) on Contents of Cantharidin-Induced Inflammatory Blisters in Subjects with Type 2 Diabetes Mellitus
200938 Withdrawn A randomized, double-blind, placebo controlled, multi-center study to evaluate the pharmacokinetics, safety and efficacy of albiglutide for the treatment of type 2 diabetes mellitus in pediatric patients
200939 Completed An open-label, randomised, cross-over, single dose study in healthy volunteers to evaluate the Unit Dose Dry Powder Inhaler (UD-DPI) with four different formulations for the delivery of fluticasone furoate and to compare the pharmacokinetic profile with the fluticasone furorate ELLIPTA presentation
200940 Completed An Open-label, Randomised, Single Dose, Three-Way Crossover, Six Sequence, Pilot Study to Determine the Relative Bioavailability of Mosapride 5mg From Two Candidate Formulations of GR107719B Relative to One 5mg Tablet of Reference Mosapride Citrate (Gasmotin) in Healthy Adult Human Subjects Under Fasting Conditions
200942 Completed A Repeat-Dose, Open-Label, Parallel-Group Study to Assess the Pharmacokinetics of GSK1278863 and Metabolites in Subjects with End Stage Renal Disease Undergoing Peritoneal Dialysis
200951 Completed A Five-cohort, Randomized, Open-label, Parallel-group Study to Evaluate the Pharmacokinetics of a Single Dose of Tafenoquine (SB252263) 300mg when Co-administered with the Artemisinin-based Combination Therapies (ACT) Artemether + Lumefantrine (AL) and Dihydroartemisinin + Piperaquine tetraphosphate (DHA+PQP) Study Listed on ClinicalStudyDataRequest.com
200952 Completed A Repeat-dose Study in Subjects with Type 2 Diabetes Mellitus to Assess the Efficacy, Safety, Tolerability and Pharmacodynamics, of Albiglutide Liquid Drug Product
200956 Completed An open-label, randomised, single dose, two-way crossover pilot study to determine the relative bioavailability of one 8mg tablet formulation of candesartan cilexetil (GW615775) relative to one 8mg reference tablet of candesartan cilexetil (Atacand) in healthy adult human subjects under fasting conditions Study Listed on ClinicalStudyDataRequest.com
200957 Completed An Open-Label, Randomised, Single Dose, Two-Way Crossover Pilot Study to Determine the Relative Bioavailability of a Fixed Dose Combination Tablet Formulation of GSK587323 (16mg Candesartan Cilexetil/12.5mg Hydrochlorothiazide) Relative to Respective Reference Dosage Atacand D in Healthy Adult Human Subjects Under Fasting Conditions Study Listed on ClinicalStudyDataRequest.com
200975 Completed A single-centre, randomized, double-blind (sponsor unblinded), placebo-controlled two-part study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of GSK2982772, in single (in both fed and fasted states) and repeat oral doses in healthy male subjects
200977 Completed Study 200977: Albiglutide + Insulin Glargine Versus Insulin Lispro + Insulin Glargine in the treatment of Subjects With Type 2 Diabetes Mellitus: The Switch Study
200980 Completed An Open Label Positron Emission Tomography (PET) Imaging Study Using 89Zirconium to Investigate the Biodistribution of Anti-HER3 monoclonal Antibody (mAb) GSK2849330 and Characterize its Dose-receptor Occupancy Relationship in Subjects with Advanced HER3-Positive Solid Tumors
200990 Active, Not Recruiting PRJ2311: Medullary Thyroid Carcinoma Surveillance Study: a Case-Series Registry
200995 Completed PGX7556: Pharmacogenetic Evaluation of FCGR in CLL patients treated with ofatumumab plus chloroambucil vs chloroambucil only
200997 Completed PGX7550: PGx Investigation of Pyrexia by Meta-Analysis of Dabrafenib/Trametinib Melanoma Studies BRF113710, BRF113929, BRF113683 and MEK115306
201000 Recruiting A randomized, double-blind, multi-dose, placebo-controlled study to evaluate the efficacy, safety and tolerability of GSK2330672 administration for the treatment of pruritus in patients with primary biliary cholangitis (GLIMMER: GSK2330672 triaL of Ibat inhibition with Multidose Measurement for Evaluation of Response)
201003 Completed An open-label study in healthy male subjects, to determine the excretion balance and pharmacokinetics of [14C]-GSK961081, administered as a single intravenous microtracer (concomitant with an inhaled non-radiolabelled dose) and a single oral dose
201010 Completed An open label, randomised, six-way crossover, single dose study to determine the pharmacokinetics of GSK961081 and fluticasone furoate when administered alone or in combination Study Listed on ClinicalStudyDataRequest.com
201011 Completed An open-label, randomised, single dose, two-way crossover pilot study to determine the relative bioavailability of one 16mg tablet formulation of candesartan cilexetil (GW615775) relative to one 16mg reference tablet of candesartan cilexetil (Atacand) in healthy adult human subjects under fasting conditions
201012 Completed Study 201012: A Dose-Finding Study of batefenterol (GSK961081) via Dry Powder Inhaler in Patients with COPD
201018 Completed HO-13-13701 - Conduct Post hoc analyses of HRQoL data collected in VEG110655 (PAzopanib in ovarian maintenance)
201020 Withdrawn A Phase I Study to Evaluate the Pharmacokinetics and Safety of Repeat Oral Doses of Dabrafenib and the combination of Dabrafenib with Trametinib in Chinese Subjects with Melanoma
201021 Withdrawn A Phase I Study to Evaluate the Pharmacokinetics and Safety of Single and Repeat Oral Doses of Trametinib in Chinese Subjects with Solid Tumours

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.